Steven Poplack, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 38 years
- Boston University School of Medicine, 1988
Offices
5 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Poplack’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G168451 · Current
Licensed to practise in California · since 2020 · expires 2028-04-30 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Radiology - Diagnostic Radiology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$36,901
Medicare paid this office $36,901 for 480 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening mammography | 142 | $5,731 | $40 |
| Screening 3d breast mammography | 141 | $4,469 | $32 |
| Screening mammography | 91 | $3,678 | $40 |
| Mri scan of both breasts | 41 | $3,667 | $89 |
| Mri scan of both breasts | 38 | $3,475 | $91 |
See all 15 services
| Screening mammography | 142 | $5,731 | $40 |
| Screening 3d breast mammography | 141 | $4,469 | $32 |
| Screening mammography | 91 | $3,678 | $40 |
| Mri scan of both breasts | 41 | $3,667 | $89 |
| Mri scan of both breasts | 38 | $3,475 | $91 |
| Screening 3d breast mammography | 91 | $2,889 | $32 |
| Diagnostic mammography of both breasts | 46 | $1,635 | $36 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 67 | $1,509 | $23 |
| Diagnostic mammography of 1 breast | 36 | $1,174 | $33 |
| Limited ultrasound scan of 1 breast | 35 | $975 | $28 |
| Diagnostic mammography of both breasts | 20 | $801 | $40 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 31 | $689 | $22 |
| Diagnostic mammography of 1 breast | 17 | $449 | $26 |
| Limited ultrasound scan of 1 breast | 16 | $435 | $27 |
| X-ray of surgical specimen | 12 | $136 | $11 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of breast and placement of locating device using ultrasound, first growth | 19 | 14 | 26 | 17 | 13 | – |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | – | 13 | – | 11 | – | – |
| Placement of locating device in breast using imaging guidance, first growth | 12 | – | – | – | – | – |
| Placement of locating device in breast using ultrasound guidance, first growth | – | – | – | 11 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
480 Original Medicare patients in 2024. Average age 73 · Under 65 5% · 85 and older 6% · Also on Medicaid 13% · Health risk score 1.00. At or below the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 54% · Cancer 50% · Diabetes 21% · Coronary heart disease 17% · Depression 16% · Chronic kidney disease 13% · Atrial fibrillation 11% · COPD 8% · Heart failure 7% · Stroke 6% · Dementia 3%.
The office billed $374,448, Medicare allowed $44,258 and paid $36,901; for 905 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 480 | 905 | 73 | 1.00 | $374,448 | $36,901 |
| 2023 | 683 | 1,320 | 73 | 0.94 | $449,954 | $55,659 |
| 2022 | 801 | 1,545 | 72 | 0.94 | $427,200 | $64,196 |
| 2021 | 717 | 1,410 | 72 | 0.80 | $405,607 | $61,485 |
| 2020 | 662 | 1,309 | 71 | 1.10 | $322,964 | $55,316 |
| 2019 | 1,033 | 2,111 | 71 | 1.01 | $258,140 | $74,981 |
| 2018 | 1,013 | 2,078 | 70 | 1.06 | $264,153 | $71,365 |
| 2017 | 997 | 1,980 | 70 | 1.11 | $254,506 | $68,058 |
| 2016 | 1,111 | 3,036 | 70 | 1.00 | $260,165 | $71,158 |
| 2015 | 928 | 2,392 | 69 | 1.04 | $198,467 | $55,403 |
| 2014 | 1,579 | 2,816 | 71 | 1.02 | $747,028 | $67,110 |
| 2013 | 1,310 | 2,417 | 71 | 1.04 | $568,993 | $57,139 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Screening mammography | 275 | $11,644 | $42 |
| Screening 3d breast mammography | 275 | $9,210 | $33 |
| Screening mammography | 102 | $4,319 | $42 |
| Screening 3d breast mammography | 102 | $3,416 | $33 |
| Mri scan of both breasts | 39 | $3,402 | $87 |
| Mri scan of both breasts | 37 | $3,080 | $83 |
| Diagnostic mammography of both breasts | 53 | $2,003 | $38 |
| Diagnostic mammography of 1 breast | 63 | $1,996 | $31 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 87 | $1,974 | $23 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 13 | $1,806 | $139 |
| Complete ultrasound scan of 1 breast | 32 | $1,483 | $46 |
| Limited ultrasound scan of 1 breast | 42 | $1,289 | $30 |
| Diagnostic mammography of both breasts | 20 | $838 | $42 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 31 | $799 | $26 |
| Diagnostic mammography of 1 breast | 20 | $679 | $34 |
| Limited ultrasound scan of 1 breast | 20 | $651 | $33 |
| X-ray of surgical specimen | 15 | $211 | $14 |
2022: 17 services
| Screening mammography | 337 | $14,228 | $42 |
| Screening 3d breast mammography | 339 | $11,468 | $34 |
| Screening mammography | 157 | $6,641 | $42 |
| Screening 3d breast mammography | 158 | $5,347 | $34 |
| Mri scan of both breasts | 53 | $4,606 | $87 |
| Mri scan of both breasts | 44 | $4,115 | $94 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 95 | $2,120 | $22 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 17 | $2,115 | $124 |
| Diagnostic mammography of 1 breast | 67 | $2,041 | $30 |
| Diagnostic mammography of both breasts | 56 | $2,041 | $36 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 11 | $1,636 | $149 |
| Limited ultrasound scan of 1 breast | 57 | $1,583 | $28 |
| Complete ultrasound scan of 1 breast | 21 | $784 | $37 |
| Placement of locating device in breast using ultrasound guidance, first growth | 11 | $769 | $70 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 18 | $402 | $22 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 18 | $302 | $16 |
| X-ray of surgical specimen | 14 | $199 | $14 |
2021: 17 services
| Screening mammography | 324 | $14,198 | $44 |
| Screening 3d breast mammography | 326 | $11,302 | $35 |
| Screening mammography | 119 | $5,206 | $44 |
| Screening 3d breast mammography | 119 | $4,119 | $35 |
| Mri scan of both breasts | 37 | $3,645 | $96 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 25 | $3,537 | $136 |
| Mri scan of both breasts | 32 | $3,054 | $95 |
| Diagnostic mammography of 1 breast | 68 | $2,323 | $33 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 83 | $1,982 | $24 |
| Diagnostic mammography of both breasts | 49 | $1,831 | $37 |
| Limited ultrasound scan of 1 breast | 47 | $1,382 | $29 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 26 | $610 | $23 |
| Diagnostic mammography of both breasts | 18 | $604 | $34 |
| Diagnostic mammography of 1 breast | 16 | $592 | $37 |
| Limited ultrasound scan of 1 breast | 12 | $393 | $33 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 12 | $288 | $22 |
| X-ray of surgical specimen | 18 | $262 | $14 |
2020: 15 services
| Screening mammography | 272 | $11,341 | $42 |
| Screening 3d breast mammography | 271 | $8,844 | $33 |
| Screening mammography | 157 | $6,591 | $42 |
| Screening 3d breast mammography | 158 | $5,195 | $33 |
| Mri scan of both breasts | 34 | $3,671 | $108 |
| Mri scan of both breasts | 26 | $2,721 | $105 |
| Diagnostic mammography of both breasts | 59 | $2,592 | $44 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 89 | $2,322 | $26 |
| Diagnostic mammography of 1 breast | 59 | $2,102 | $34 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 13 | $1,995 | $153 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 14 | $1,865 | $133 |
| Limited ultrasound scan of 1 breast | 52 | $1,571 | $29 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 15 | $397 | $26 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 12 | $310 | $22 |
| X-ray of surgical specimen | 14 | $199 | $14 |
2019: 12 services
| Screening mammography | 535 | $20,532 | $38 |
| Screening 3d breast mammography | 533 | $16,098 | $30 |
| Screening mammography | 289 | $11,112 | $38 |
| Screening 3d breast mammography | 288 | $8,715 | $30 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 131 | $3,054 | $23 |
| Diagnostic mammography of 1 breast | 97 | $3,031 | $30 |
| Diagnostic mammography of both breasts | 76 | $2,990 | $39 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 19 | $2,414 | $127 |
| Mri scan of both breasts | 23 | $2,152 | $90 |
| Limited ultrasound scan of 1 breast | 47 | $1,338 | $26 |
| Placement of locating device in breast using imaging guidance, first growth | 12 | $996 | $83 |
| X-ray of surgical specimen | 15 | $98 | $7 |
2018: 14 services
| Screening mammography | 564 | $21,283 | $38 |
| Screening 3d breast mammography | 524 | $15,558 | $30 |
| Screening mammography | 176 | $6,648 | $38 |
| Screening 3d breast mammography | 163 | $4,844 | $30 |
| Diagnostic mammography of both breasts | 116 | $4,318 | $37 |
| Diagnostic mammography of 1 breast | 131 | $3,946 | $29 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 180 | $3,929 | $22 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 20 | $2,558 | $128 |
| Limited ultrasound scan of 1 breast | 82 | $2,244 | $26 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 13 | $1,768 | $136 |
| MRI scan of both breasts with contrast | 25 | $1,465 | $59 |
| Placement of locating device in breast using imaging guidance, first growth | 13 | $1,060 | $82 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 14 | $274 | $18 |
| X-ray of surgical specimen | 16 | $116 | $6 |
2017: 12 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 645 | $23,516 | $36 |
| Screening 3d breast mammography | 598 | $17,889 | $30 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 120 | $4,525 | $38 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 136 | $4,209 | $29 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 178 | $4,125 | $23 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 18 | $2,553 | $134 |
| Limited ultrasound scan of 1 breast | 87 | $2,385 | $25 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 19 | $2,374 | $119 |
| MRI scan of both breasts with contrast | 29 | $1,876 | $65 |
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 46 | $1,684 | $37 |
| Screening 3d breast mammography | 44 | $1,317 | $30 |
| X-ray of surgical specimen | 12 | $77 | $6 |
2016: 12 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 816 | $27,951 | $34 |
| Screening 3d breast mammography | 610 | $17,978 | $29 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 141 | $3,952 | $26 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 124 | $3,848 | $31 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 161 | $3,556 | $22 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 21 | $2,836 | $135 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 21 | $2,489 | $119 |
| Limited ultrasound scan of 1 breast | 87 | $2,470 | $26 |
| Computer analysis of screening mammogram to assist detection of cancer | 815 | $2,249 | $3 |
| MRI scan of both breasts with contrast | 23 | $1,530 | $64 |
| Computer analysis of diagnostic mammogram | 147 | $299 | $2 |
| X-ray of surgical specimen | 12 | $77 | $6 |
2015: 11 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 687 | $23,671 | $34 |
| Screening 3d breast mammography | 372 | $10,996 | $30 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 115 | $3,928 | $34 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 113 | $3,081 | $25 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 133 | $3,063 | $23 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 17 | $2,223 | $131 |
| Computer analysis of screening mammogram to assist detection of cancer | 688 | $2,163 | $3 |
| Limited ultrasound scan of 1 breast | 71 | $2,003 | $26 |
| MRI scan of both breasts with contrast | 13 | $843 | $65 |
| Computer analysis of diagnostic mammogram | 112 | $271 | $2 |
| X-ray of surgical specimen | 14 | $96 | $6 |
2014: 35 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 750 | $26,265 | $35 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 30 | $4,292 | $143 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 31 | $3,860 | $121 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 122 | $3,409 | $25 |
| Ct scan of abdomen and pelvis with contrast | 46 | $3,299 | $72 |
| Computer analysis of screening mammogram to assist detection of cancer | 748 | $2,356 | $3 |
| MRI scan of both breasts with contrast | 36 | $2,142 | $60 |
| Ultrasound of breasts | 96 | $2,008 | $20 |
| Complete ultrasound scan behind abdominal cavity | 73 | $1,957 | $26 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 24 | $1,721 | $72 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 55 | $1,720 | $31 |
| Complete ultrasound scan of abdomen | 44 | $1,392 | $32 |
| Ct scan of chest with contrast | 26 | $1,115 | $43 |
| Placement of locating device in breast using ultrasound guidance, first growth | 13 | $850 | $65 |
| Ct scan of blood vessels of chest with contrast | 11 | $850 | $77 |
| Limited ultrasound scan of abdomen | 38 | $728 | $19 |
| X-ray of chest, 2 views, front and side | 60 | $518 | $9 |
| X-ray of chest, 1 view, front | 43 | $346 | $7 |
| Injection of radioactive material for x-ray identification of lymph node | 18 | $341 | $19 |
| X-ray of pelvis, 1-2 views | 54 | $341 | $6 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 11 | $306 | $28 |
| Ultrasound scan of pelvic region through rectum | 11 | $270 | $25 |
| Ultrasound scan of head and neck soft tissue | 15 | $249 | $17 |
| X-ray of knee, 1-2 views | 27 | $235 | $6 |
| X-ray of hip on one side of body, 1 view | 33 | $220 | $6 |
| X-ray of knee, 4 or more views | 15 | $191 | $10 |
| X-ray of abdomen, single view | 19 | $169 | $7 |
| X-ray of surgical specimen | 23 | $150 | $7 |
| X-ray of foot, minimum of 3 views | 15 | $136 | $7 |
| Other diagnostic imaging procedure | 17 | $134 | $8 |
| X-ray of shoulder, minimum of 2 views | 16 | $120 | $8 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $105 | $9 |
| X-ray of ribs of one side of body, minimum of 2 views | 15 | $102 | $7 |
| X-ray of wrist, minimum of 3 views | 14 | $99 | $7 |
| Computer analysis of diagnostic mammogram | 25 | $63 | $3 |
2013: 32 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 639 | $21,978 | $34 |
| Biopsy of breast using imaging guidance | 28 | $4,232 | $141 |
| Ct scan of abdomen and pelvis with contrast | 54 | $3,672 | $66 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 107 | $2,427 | $22 |
| MRI scan of both breasts with contrast | 41 | $2,324 | $57 |
| Ct scan of chest with contrast | 56 | $2,276 | $41 |
| Biopsy of breast using imaging guidance | 22 | $1,968 | $73 |
| Computer analysis of screening mammogram to assist detection of cancer | 639 | $1,913 | $3 |
| Ultrasound of breasts | 85 | $1,640 | $19 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 43 | $1,360 | $31 |
| Radiological supervision and interpretation of imaging guidance for breast biopsy or insertion of needle | 21 | $1,355 | $62 |
| Complete ultrasound scan behind abdominal cavity | 44 | $1,210 | $27 |
| Ultrasonic guidance for needle placement | 33 | $1,018 | $24 |
| Ct scan of abdomen and pelvis without contrast | 14 | $929 | $66 |
| Presurgical insertion of needle wire to localize breast growth | 11 | $530 | $48 |
| Complete ultrasound scan of abdomen | 17 | $525 | $29 |
| Ct scan of chest without contrast | 13 | $505 | $39 |
| Injection of radioactive material for x-ray identification of lymph node | 13 | $377 | $25 |
| Limited ultrasound scan of abdomen | 15 | $307 | $20 |
| X-ray of pelvis, 1-2 views | 48 | $281 | $6 |
| X-ray of surgical specimen | 36 | $236 | $6 |
| X-ray of chest, 2 views, front and side | 32 | $231 | $7 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 13 | $225 | $16 |
| X-ray of chest, 1 view, front | 27 | $190 | $7 |
| X-ray of ribs of one side of body, minimum of 2 views | 20 | $176 | $9 |
| X-ray of knee, 4 or more views | 15 | $168 | $9 |
| X-ray of hip on one side of body, 1 view | 20 | $157 | $6 |
| X-ray of lower and sacral spine, 2-3 views | 18 | $115 | $6 |
| X-ray of knee, 1-2 views | 11 | $105 | $7 |
| X-ray of thigh, 2 views | 12 | $80 | $6 |
| X-ray of shoulder, minimum of 2 views | 12 | $77 | $6 |
| Computer analysis of diagnostic mammogram | 22 | $44 | $2 |
Medicaid work
$100 in 2023
Medicaid paid $100 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 12 | $100 |
| 2023 | 12 | 1 | 12 | $100 |
| 2022 | 66 | 2 | 17 | $797 |
| 2021 | 62 | 2 | 13 | $1,176 |
| 2020 | 148 | 2 | 25 | $2,985 |
| 2019 | 269 | 4 | 23 | $4,564 |
| 2018 | 86 | 1 | 23 | $1,559 |
See the largest Medicaid services in earlier years
2022
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 50 | $573 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 16 | $224 |
2021
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 38 | $808 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 24 | $369 |
2020
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 74 | $1,629 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 74 | $1,356 |
2019
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 120 | $2,182 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 119 | $1,863 |
| DIAGNOSTIC MAMMOGRAPHY COMPUTER-AIDED DETCJ BI | 14 | $284 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 16 | $237 |
2018
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 86 | $1,559 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1285667378
- Licence
- CA G168451, MO 2015005803California G168451: Current · expires 2028-04-30
- Trained
- Boston University School of Medicine, 1988 · 38 years ago
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IL ENROLLED, MO 1285667378
- Taxonomy
- Diagnostic radiology (2085R0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-09
- NPI last updated
- 2024-04-07
- NPI record certified
- 2024-04-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 510 S Kingshighway Blvd, Saint Louis, MO, 63110 · 660 S Euclid Ave, Saint Louis, MO, 63110